Wisconsin health plan increases availability of Freespira digital therapeutic due to strong clinical outcomes and high prevalence of undiagnosed panic…
Study conducted by Stanford University researchers at a Veterans Affairs medical center finds Freespira digital therapeutic reduced symptoms of post-traumatic…
Freespira CEO Dean Sawyer said its FDA cleared digital therapeutic is the first that’s proven to significantly reduce or eliminate…
Former Blue Cross Blue Shield Health Plan chief medical officer and chief healthcare strategist brings clinical, quality and business insights…
Platinum award recognizes Freespira’s ground-breaking treatment providing relief for patients with panic attacks, panic disorder, and post-traumatic stress disorder KIRKLAND,…
We’ve long known that the coronavirus pandemic would dramatically impact the mental health of health care professionals and the general…
Study in Journal of Mental Health and Clinic Psychology Confirms Freespira Drastically Reduces Panic Disorder Severity KIRKLAND, Wash., April 28, 2021…
Market Watch | March 17, 2021 ‘Although serious illness from COVID-19 is uncommon among teens, the changes brought on by…
Former Livongo, 23andMe, Allscripts, Healthways and LabCorp leader brings unique expertise to digital therapeutic company PR Newswire | March 16th,…
